Treatment of hepatosplenic candidiasis with liposomal-amphotericin B.

Nine patients with hematologic malignancies developed fungal infections, predominantly involving the liver and spleen. Eight patients had biopsy-documented progressive candidiasis and one had an unclassified fungus. The patients were treated with liposomal-amphotericin B (L-AmpB) after their fungal infection progressed during treatment with standard intravenous (IV) AmpB (Fungizone; E. R. Squibb & Son, Princeton, NJ) and/or other antifungals. Eight patients (88.8%) were cured of their fungal infection, and one showed improvement after treatment. Minor acute toxicity and no chronic toxicity were associated with the administration of L-AmpB. L-AmpB is a safe and effective therapeutic method for treating fungal infections that have invaded the liver and spleen even when they are refractory to conventional anti-fungal therapy.

[1]  J. Reuben,et al.  Liposomal amphotericin B for the treatment of systemic fungal infections in patients with cancer: a preliminary study. , 1985, The Journal of infectious diseases.

[2]  K. Mehta,et al.  Effect of liposomal amphotericin B on murine macrophages and lymphocytes , 1985, Infection and immunity.

[3]  G. Bodey.  Candidiasis in cancer patients. , 1984, The American journal of medicine.

[4]  S. Thongprasert,et al.  Systemic candidiasis in cancer patients. , 1984, The American journal of medicine.

[5]  M. Raff,et al.  Fungal splenic abscess. , 1984, Archives of internal medicine.

[6]  J. Abramson,et al.  Focal hepatic candidiasis: a distinct clinical variant of candidiasis in immunocompromised patients. , 1984, Reviews of infectious diseases.

[7]  E. Hersh,et al.  Liposome-encapsulated amphotericin B for treatment of disseminated candidiasis in neutropenic mice. , 1984, The Journal of infectious diseases.

[8]  G. Lopez-Berestein,et al.  Liposomal amphotericin B is toxic to fungal cells but not to mammalian cells. , 1984, Biochimica et biophysica acta.

[9]  J. Gold.  Opportunistic fungal infections in patients with neoplastic disease. , 1984, The American journal of medicine.

[10]  E. Hersh,et al.  Prophylaxis of Candida albicans infection in neutropenic mice with liposome-encapsulated amphotericin B , 1984, Antimicrobial Agents and Chemotherapy.

[11]  G. Lopez-Berestein,et al.  Altered tissue distribution of amphotericin B by liposomal encapsulation: comparison of normal mice to mice infected with Candida albicans. , 1984, Cancer drug delivery.

[12]  E. Hersh,et al.  Distribution and pharmacology of intravenous 99mTc-labeled multilamellar liposomes in rats and mice. , 1984, International journal of nuclear medicine and biology.

[13]  E. Hersh,et al.  Clinical pharmacology of 99mTc-labeled liposomes in patients with cancer. , 1984, Cancer research.

[14]  E. Hersh,et al.  Treatment and prophylaxis of disseminated infection due to Candida albicans in mice with liposome-encapsulated amphotericin B. , 1983, The Journal of infectious diseases.

[15]  E. Hersh,et al.  Effects of sterols on the therapeutic efficacy of liposomal amphotericin B in murine candidiasis. , 1983, Cancer drug delivery.

[16]  W. Lee,et al.  Fungal infections in patients with acute leukemia. , 1982, The American journal of medicine.

[17]  J. Graybill,et al.  Amphotericin B in liposomes: a novel therapy for histoplasmosis. , 1982, The American review of respiratory disease.

[18]  P. Pizzo,et al.  Fever in the Pediatric and Young Adult Patient with Cancer: A PROSPECTIVE STUDY OF 1001 EPISODES , 1982, Medicine.

[19]  L. Young.  Nosocomial infections in the immunocompromised adult. , 1981, The American journal of medicine.

[20]  R. New,et al.  The treatment of experimental cutaneous leishmaniasis with liposome-entrapped Pentostam , 1980, Parasitology.

[21]  Edwards Je,et al.  Severe Candidal Infections: Clinical Perspective, Immune Defense Mechanisms, and Current Concepts of Therapy , 1978 .

[22]  G. Bodey,et al.  Fever and infection in leukemic patients. A study of 494 consecutive patients , 1978, Cancer.

[23]  R. Myerowitz,et al.  Disseminated candidiasis. Changes in incidence, underlying diseases, and pathology. , 1977, American journal of clinical pathology.

[24]  J. Cuttner,et al.  Fungal infection in acute leukemia , 1972, Cancer.

[25]  G. Bodey.  Fungal infections complicating acute leukemia. , 1966, Journal of chronic diseases.